MoneyWorks4Me

Wockhardt informs about press release

01 Dec 2025 Evaluate
Pursuant to Regulation 30 of Listing Regulations, Wockhardt has enclosed Press Release - ‘US FDA Accepts Wockhardt’s New Drug Application for Breakthrough Antibiotic Zaynich’. A copy of the same will also be uploaded on the Company’s website www.wockhardt.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..